Works by Krex, Dietmar


Results: 57
    1
    2

    Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial.

    Published in:
    Trials, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13063-021-05977-0
    By:
    • Zeyen, Thomas;
    • Potthoff, Anna-Laura;
    • Nemeth, Robert;
    • Heiland, Dieter H.;
    • Burger, Michael C.;
    • Steinbach, Joachim P.;
    • Hau, Peter;
    • Tabatabai, Ghazaleh;
    • Glas, Martin;
    • Schlegel, Uwe;
    • Grauer, Oliver;
    • Krex, Dietmar;
    • Schnell, Oliver;
    • Goldbrunner, Roland;
    • Sabel, Michael;
    • Thon, Niklas;
    • Delev, Daniel;
    • Clusmann, Hans;
    • Seidel, Clemens;
    • Güresir, Erdem
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide.

    Published in:
    Journal of Neuro-Oncology, 2010, v. 96, n. 3, p. 393, doi. 10.1007/s11060-009-9976-3
    By:
    • Dresemann, Gregor;
    • Weller, Michael;
    • Rosenthal, Mark A.;
    • Wedding, Ulrich;
    • Wagner, Wolfgang;
    • Engel, Erik;
    • Heinrich, Bernhard;
    • Mayer-Steinacker, Regine;
    • Karup-Hansen, Anders;
    • Fluge, Øystein;
    • Nowak, Anna;
    • Mehdorn, Maximilian;
    • Schleyer, Eberhard;
    • Krex, Dietmar;
    • Olver, Ian N.;
    • Steinbach, Joachim P.;
    • Hosius, Christian;
    • Sieder, Christian;
    • Sorenson, Greg;
    • Parker, Richard
    Publication type:
    Article
    9

    Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma.

    Published in:
    Acta Neuropathologica, 2024, v. 147, n. 1, p. 1, doi. 10.1007/s00401-023-02662-1
    By:
    • Weller, Michael;
    • Felsberg, Jörg;
    • Hentschel, Bettina;
    • Gramatzki, Dorothee;
    • Kubon, Nadezhda;
    • Wolter, Marietta;
    • Reusche, Matthias;
    • Roth, Patrick;
    • Krex, Dietmar;
    • Herrlinger, Ulrich;
    • Westphal, Manfred;
    • Tonn, Joerg C.;
    • Regli, Luca;
    • Maurage, Claude-Alain;
    • von Deimling, Andreas;
    • Pietsch, Torsten;
    • Le Rhun, Emilie;
    • Reifenberger, Guido
    Publication type:
    Article
    10

    INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas.

    Published in:
    Neurological Research & Practice, 2023, v. 5, n. 1, p. 1, doi. 10.1186/s42466-023-00282-4
    By:
    • Grassl, Niklas;
    • Sahm, Katharina;
    • Süße, Heike;
    • Poschke, Isabel;
    • Bunse, Lukas;
    • Bunse, Theresa;
    • Boschert, Tamara;
    • Mildenberger, Iris;
    • Rupp, Anne-Kathleen;
    • Ewinger, Max Philipp;
    • Lanz, Lisa-Marie;
    • Denk, Monika;
    • Tabatabai, Ghazaleh;
    • Ronellenfitsch, Michael W.;
    • Herrlinger, Ulrich;
    • Glas, Martin;
    • Krex, Dietmar;
    • Vajkoczy, Peter;
    • Wick, Antje;
    • Harting, Inga
    Publication type:
    Article
    11
    12

    Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide.

    Published in:
    Neuro-Oncology, 2025, v. 27, n. 2, p. 557, doi. 10.1093/neuonc/noae205
    By:
    • Zeyen, Thomas;
    • Böhm, Laura;
    • Paech, Daniel;
    • Schäfer, Niklas;
    • Tzaridis, Theophilos;
    • Duffy, Cathrina;
    • Nitsch, Louisa;
    • Schneider, Matthias;
    • Potthoff, Anna-Laura;
    • Schneider-Rothhaar, Javen Lennard;
    • Steinbach, Joachim Peter;
    • Hau, Peter;
    • Kowalski, Thomas;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Grauer, Oliver;
    • Goldbrunner, Roland;
    • Zeiner, Pia Susan;
    • Tabatabai, Ghazaleh;
    • Galldiks, Norbert
    Publication type:
    Article
    13

    Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.

    Published in:
    EMBO Molecular Medicine, 2016, v. 8, n. 1, p. 39, doi. 10.15252/emmm.201505505
    By:
    • Scholz, Alexander;
    • Harter, Patrick N;
    • Cremer, Sebastian;
    • Yalcin, Burak H;
    • Gurnik, Stefanie;
    • Yamaji, Maiko;
    • Di Tacchio, Mariangela;
    • Sommer, Kathleen;
    • Baumgarten, Peter;
    • Bähr, Oliver;
    • Steinbach, Joachim P;
    • Trojan, Jörg;
    • Glas, Martin;
    • Herrlinger, Ulrich;
    • Krex, Dietmar;
    • Meinhardt, Matthias;
    • Weyerbrock, Astrid;
    • Timmer, Marco;
    • Goldbrunner, Roland;
    • Deckert, Martina
    Publication type:
    Article
    14
    15
    16

    The Stem Cell Marker Prominin-1/CD133 on Membrane Particles in Human Cerebrospinal Fluid Offers Novel Approaches for Studying Central Nervous System Disease.

    Published in:
    Stem Cells, 2008, v. 26, n. 3, p. 698, doi. 10.1634/stemcells.2007-0639
    By:
    • Huttner, Hagen B.;
    • Janich, Peggy;
    • Köhrmann, Martin;
    • Jászai, József;
    • Siebzehnrubl, Florian;
    • Blümcke, Ingmar;
    • Suttorp, Meinolf;
    • Gahr, Manfred;
    • Kuhnt, Daniela;
    • Nimsky, Christopher;
    • Krex, Dietmar;
    • Schackert, Gabriele;
    • Löwenbrück, Kai;
    • Reichmann, Heinz;
    • Jüttler, Eric;
    • Hacke, Werner;
    • Schellinger, Peter D.;
    • Schwab, Stefan;
    • Wilsch-Bräuninger, Michaela;
    • Marzesco, Anne-Marie
    Publication type:
    Article
    17
    18
    19
    20
    21

    Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 7, p. 975, doi. 10.1093/neuonc/nox204
    By:
    • Schäfer, Niklas;
    • Proescholdt, Martin;
    • Steinbach, Joachim P.;
    • Weyerbrock, Astrid;
    • Hau, Peter;
    • Grauer, Oliver;
    • Goldbrunner, Roland;
    • Friedrich, Franziska;
    • Rohde, Veit;
    • Ringel, Florian;
    • Schlegel, Uwe;
    • Sabel, Michael;
    • Ronellenfitsch, Michael W.;
    • Uhl, Martin;
    • Grau, Stefan;
    • Hänel, Mathias;
    • Schnell, Oliver;
    • Krex, Dietmar;
    • Vajkoczy, Peter;
    • Tabatabai, Ghazaleh
    Publication type:
    Article
    22

    Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 3, p. 367, doi. 10.1093/neuonc/nox160
    By:
    • Kessler, Tobias;
    • Sahm, Felix;
    • Sadik, Ahmed;
    • Stichel, Damian;
    • Hertenstein, Anne;
    • Reifenberger, Guido;
    • Zacher, Angela;
    • Sabel, Michael;
    • Tabatabai, Ghazaleh;
    • Steinbach, Joachim;
    • Sure, Ulrich;
    • Krex, Dietmar;
    • Grosu, Anca-L.;
    • Bewerunge-Hudler, Melanie;
    • Jones, David;
    • Pfister, Stefan M.;
    • Weller, Michael;
    • Opitz, Christiane;
    • Bendszus, Martin;
    • von Deimling, Andreas
    Publication type:
    Article
    23

    Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 4, p. 546, doi. 10.1093/neuonc/now231
    By:
    • Abou-El-Ardat, Khalil;
    • Seifert, Michael;
    • Becker, Kerstin;
    • Eisenreich, Sophie;
    • Lehmann, Matthias;
    • Hackmann, Karl;
    • Rump, Andreas;
    • Meijer, Gerrit;
    • Carvalho, Beatriz;
    • Temme, Achim;
    • Schackert, Gabriele;
    • Schröck, Evelin;
    • Krex, Dietmar;
    • Klink, Barbara
    Publication type:
    Article
    24
    25

    End-of-life caregivers' perception of medical and psychological support during the final weeks of glioma patients: a questionnaire-based survey.

    Published in:
    Neuro-Oncology, 2013, v. 15, n. 9, p. 1251, doi. 10.1093/neuonc/not089
    By:
    • Heese, Oliver;
    • Vogeler, Eva;
    • Martens, Tobias;
    • Schnell, Oliver;
    • Tonn, Jörg-Christian;
    • Simon, Matthias;
    • Schramm, Johannes;
    • Krex, Dietmar;
    • Schackert, Gabriele;
    • Reithmeier, Thomas;
    • Nikkhah, Guido;
    • Sabel, Michael;
    • Steiger, Hans-Jakob;
    • Schlegel, Uwe;
    • Löffler, Markus;
    • Weller, Michael;
    • Westphal, Manfred
    Publication type:
    Article
    26
    27

    MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA‐09 trial.

    Published in:
    International Journal of Cancer, 2021, v. 148, n. 7, p. 1695, doi. 10.1002/ijc.33363
    By:
    • Tzaridis, Theophilos;
    • Schäfer, Niklas;
    • Weller, Johannes;
    • Steinbach, Joachim‐Peter;
    • Schlegel, Uwe;
    • Seidel, Sabine;
    • Sabel, Michael;
    • Hau, Peter;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Goldbrunner, Roland;
    • Tonn, Jörg‐Christian;
    • Grauer, Oliver;
    • Kebir, Sied;
    • Schneider, Matthias;
    • Schaub, Christina;
    • Vatter, Hartmut;
    • Coch, Christoph;
    • Glas, Martin;
    • Fimmers, Rolf
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34

    Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.

    Published in:
    2023
    By:
    • Zeyen, Thomas;
    • Paech, Daniel;
    • Weller, Johannes;
    • Schäfer, Niklas;
    • Tzaridis, Theophilos;
    • Duffy, Cathrina;
    • Nitsch, Louisa;
    • Schneider, Matthias;
    • Potthoff, Anna-Laura;
    • Steinbach, Joachim Peter;
    • Hau, Peter;
    • Schlegel, Uwe;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Grauer, Oliver;
    • Goldbrunner, Roland;
    • Zeiner, Pia Susan;
    • Tabatabai, Ghazaleh;
    • Galldiks, Norbert;
    • Stummer, Walter
    Publication type:
    Correction Notice
    35

    Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.

    Published in:
    Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 607, doi. 10.1007/s11060-023-04444-x
    By:
    • Zeyen, Thomas;
    • Paech, Daniel;
    • Weller, Johannes;
    • Schäfer, Niklas;
    • Tzaridis, Theophilos;
    • Duffy, Cathrina;
    • Nitsch, Louisa;
    • Schneider, Matthias;
    • Potthoff, Anna-Laura;
    • Steinbach, Joachim Peter;
    • Hau, Peter;
    • Schlegel, Uwe;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Grauer, Oliver;
    • Goldbrunner, Roland;
    • Zeiner, Pia Susan;
    • Tabatabai, Ghazaleh;
    • Galldiks, Norbert;
    • Stummer, Walter
    Publication type:
    Article
    36

    Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up.

    Published in:
    Journal of Neuro-Oncology, 2023, v. 164, n. 2, p. 353, doi. 10.1007/s11060-023-04419-y
    By:
    • Pertz, Milena;
    • Schlömer, Sabine;
    • Seidel, Clemens;
    • Hentschel, Bettina;
    • Löffler, Markus;
    • Schackert, Gabriele;
    • Krex, Dietmar;
    • Juratli, Tareq;
    • Tonn, Joerg Christian;
    • Schnell, Oliver;
    • Vatter, Hartmut;
    • Simon, Matthias;
    • Westphal, Manfred;
    • Martens, Tobias;
    • Sabel, Michael;
    • Bendszus, Martin;
    • Dörner, Nils;
    • Wick, Antje;
    • Fliessbach, Klaus;
    • Hoppe, Christian
    Publication type:
    Article
    37

    Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS.

    Published in:
    Journal of Neuro-Oncology, 2022, v. 159, n. 1, p. 95, doi. 10.1007/s11060-022-04046-z
    By:
    • Weller, Johannes;
    • Schäfer, Niklas;
    • Schaub, Christina;
    • Potthoff, Anna-Laura;
    • Steinbach, Joachim P.;
    • Schlegel, Uwe;
    • Sabel, Michael;
    • Hau, Peter;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Goldbrunner, Roland;
    • Pietsch, Torsten;
    • Tzaridis, Theophilos;
    • Zeyen, Thomas;
    • Borger, Valeri;
    • Güresir, Erdem;
    • Vatter, Hartmut;
    • Herrlinger, Ulrich;
    • Schneider, Matthias
    Publication type:
    Article
    38

    Mid-term treatment-related cognitive sequelae in glioma patients.

    Published in:
    Journal of Neuro-Oncology, 2022, v. 159, n. 1, p. 65, doi. 10.1007/s11060-022-04044-1
    By:
    • Schlömer, Sabine;
    • Felsberg, Jörg;
    • Pertz, Milena;
    • Hentschel, Bettina;
    • Löffler, Markus;
    • Schackert, Gabriele;
    • Krex, Dietmar;
    • Juratli, Tareq;
    • Tonn, Joerg Christian;
    • Schnell, Oliver;
    • Vatter, Hartmut;
    • Simon, Matthias;
    • Westphal, Manfred;
    • Martens, Tobias;
    • Sabel, Michael;
    • Bendszus, Martin;
    • Dörner, Nils;
    • Fliessbach, Klaus;
    • Hoppe, Christian;
    • Reifenberger, Guido
    Publication type:
    Article
    39
    40
    41
    42

    Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.

    Published in:
    2022
    By:
    • Zeyen, Thomas;
    • Potthoff, Anna-Laura;
    • Nemeth, Robert;
    • Heiland, Dieter H.;
    • Burger, Michael C.;
    • Steinbach, Joachim P.;
    • Hau, Peter;
    • Tabatabai, Ghazaleh;
    • Glas, Martin;
    • Schlegel, Uwe;
    • Grauer, Oliver;
    • Krex, Dietmar;
    • Schnell, Oliver;
    • Goldbrunner, Roland;
    • Sabel, Michael;
    • Thon, Niklas;
    • Delev, Daniel;
    • Clusmann, Hans;
    • Seidel, Clemens;
    • Güresir, Erdem
    Publication type:
    journal article
    43
    44
    45
    46
    47

    Novel <i>CIC</i> Point Mutations and an Exon-Spanning, Homozygous Deletion Identified in Oligodendroglial Tumors by a Comprehensive Genomic Approach Including Transcriptome Sequencing.

    Published in:
    PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0076623
    By:
    • Eisenreich, Sophie;
    • Abou-El-Ardat, Khalil;
    • Szafranski, Karol;
    • Campos Valenzuela, Jaime A.;
    • Rump, Andreas;
    • Nigro, Janice M.;
    • Bjerkvig, Rolf;
    • Gerlach, Eva-Maria;
    • Hackmann, Karl;
    • Schröck, Evelin;
    • Krex, Dietmar;
    • Kaderali, Lars;
    • Schackert, Gabriele;
    • Platzer, Matthias;
    • Klink, Barbara
    Publication type:
    Article
    48
    49
    50